These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21884674)
21. [Electrical storm in Brugada syndrome successfully treated with isoproterenol. Report of a case]. Vega J; Enríquez A; Vergara I; Frangini P; Baeza M; Millapán I; González R Rev Med Chil; 2013 Oct; 141(10):1340-3. PubMed ID: 24522365 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of bepridil for prevention of ICD shocks in patients with Brugada syndrome and idiopathic ventricular fibrillation. Aizawa Y; Yamakawa H; Takatsuki S; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Fukumoto K; Tanimoto Y; Tanimoto K; Mitamura H; Ogawa S; Fukuda K Int J Cardiol; 2013 Oct; 168(5):5083-5. PubMed ID: 23954005 [No Abstract] [Full Text] [Related]
23. Response to letter from Drs. Li et al. regarding our paper in Int. J. Cardiol. 2018. Doi: 10.1016/j.ijcard.2017.09.010: SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers. Amin AS; Wilde AAM; Tan HL Int J Cardiol; 2018 Nov; 271():124. PubMed ID: 30223346 [No Abstract] [Full Text] [Related]
24. Editorial commentary: Who is at high-risk in J wave syndromes? Morita H; Miyamoto M Trends Cardiovasc Med; 2022 Aug; 32(6):364-365. PubMed ID: 34389408 [No Abstract] [Full Text] [Related]
25. Ventricular arrhythmias treated by diazepam. Van Loon GR Can Med Assoc J; 1968 Apr; 98(16):785-7. PubMed ID: 5646118 [No Abstract] [Full Text] [Related]
26. Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome. Nattel S Heart Rhythm; 2005 Mar; 2(3):261-2. PubMed ID: 15851315 [No Abstract] [Full Text] [Related]
27. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity. Bonatti R; Silva AF; Batatinha JA; Sobrado LF; Machado AD; Varone BB; Nearing BD; Belardinelli L; Verrier RL Heart Rhythm; 2014 Oct; 11(10):1827-35. PubMed ID: 24953379 [TBL] [Abstract][Full Text] [Related]
28. Insight into specific pro-arrhythmic triggers in Brugada and early repolarization syndromes: results of long-term follow-up. Talib AK; Sato N; Myojo T; Sugiyama E; Nakagawa N; Sakamoto N; Tanabe Y; Fujino T; Takeuchi T; Akasaka K; Matsuhashi H; Saijo Y; Kawamura Y; Doi A; Hasebe N Heart Vessels; 2016 Dec; 31(12):2035-2044. PubMed ID: 26968993 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501 [TBL] [Abstract][Full Text] [Related]
30. Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome. Frommeyer G; Ellermann C; Dechering DG; Kochhäuser S; Bögeholz N; Güner F; Leitz P; Pott C; Eckardt L J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1214-1219. PubMed ID: 27283775 [TBL] [Abstract][Full Text] [Related]
31. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877 [TBL] [Abstract][Full Text] [Related]
32. Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome. Brugada R; Brugada P; Brugada J J Electrocardiol; 2006 Oct; 39(4 Suppl):S115-8. PubMed ID: 16934827 [TBL] [Abstract][Full Text] [Related]
33. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity. Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944 [TBL] [Abstract][Full Text] [Related]
34. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Fish JM; Welchons DR; Kim YS; Lee SH; Ho WK; Antzelevitch C Circulation; 2006 Mar; 113(11):1393-400. PubMed ID: 16534004 [TBL] [Abstract][Full Text] [Related]
35. A phenotypic combination of idiopathic VF and Brugada syndrome. Martinek M; Purerfellner H Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation. Justo F; Fuller H; Nearing BD; Rajamani S; Belardinelli L; Verrier RL Heart Rhythm; 2016 Sep; 13(9):1860-7. PubMed ID: 27317981 [TBL] [Abstract][Full Text] [Related]